chr14-100239438-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_003403.5(YY1):āc.194A>Gā(p.His65Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000408 in 1,588,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H65Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_003403.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
YY1 | NM_003403.5 | c.194A>G | p.His65Arg | missense_variant | 1/5 | ENST00000262238.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
YY1 | ENST00000262238.10 | c.194A>G | p.His65Arg | missense_variant | 1/5 | 1 | NM_003403.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000275 AC: 40AN: 145592Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000129 AC: 27AN: 209582Hom.: 0 AF XY: 0.000138 AC XY: 16AN XY: 116192
GnomAD4 exome AF: 0.000421 AC: 608AN: 1443234Hom.: 0 Cov.: 33 AF XY: 0.000396 AC XY: 284AN XY: 717076
GnomAD4 genome AF: 0.000275 AC: 40AN: 145714Hom.: 0 Cov.: 29 AF XY: 0.000266 AC XY: 19AN XY: 71372
ClinVar
Submissions by phenotype
Gabriele de Vries syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 02, 2019 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | YY1: PP2 - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at